Acquisition by Sanders Corazon D. of 1000 shares of Molecular Templates at 1.41 subject to Rule 16b-3

About 67% of Molecular Templates' investor base is looking to short. The analysis of overall sentiment of trading Molecular Templates otc stock suggests that many investors are alarmed at this time. Molecular Templates' investing sentiment overview a quick insight into current market opportunities from investing in Molecular Templates. Many technical investors use Molecular Templates stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Molecular Templates otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Molecular daily returns and investor perception about the current price of Molecular Templates as well as its diversification or hedging effects on your existing portfolios.
  
Filed transaction by Molecular Templates Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at news.google.com
Google News at Macroaxis
  
Acquisition of 1000 stock option (right to buy) at 1.41 of Molecular Templates by Sanders Corazon (corsee) D. on 27th of September 2024. This event was filed by Molecular Templates with SEC on 2024-09-27. Statement of changes in beneficial ownership - SEC Form 4

Molecular Templates Fundamental Analysis

We analyze Molecular Templates' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Molecular Templates using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Molecular Templates based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Asset

Net Asset Comparative Analysis

Molecular Templates is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Molecular Templates Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Molecular Templates otc stock to make a market-neutral strategy. Peer analysis of Molecular Templates could also be used in its relative valuation, which is a method of valuing Molecular Templates by comparing valuation metrics with similar companies.

Peers

Molecular Templates Related Equities

MLYSMineralys Therapeutics,   10.50   
0%
100.0%
ASMBAssembly Biosciences   7.86   
0%
74.0%
SRZNSurrozen   7.48   
0%
71.0%
RNXTRenovoRx   4.12   
0%
39.0%
MNPRMonopar Therapeutics   0.58   
0%
5.0%
KZRKezar Life   0.17   
0%
1.0%
TARAProtara Therapeutics   0.57   
5.0%
0%
FBRXForte Biosciences   0.64   
6.0%
0%
ERASErasca   0.71   
6.0%
0%
TILInstil Bio   0.74   
7.0%
0%
IPSCCentury Therapeutics   1.43   
13.0%
0%
NUVBNuvation Bio   1.44   
13.0%
0%
CTMXCytomX Therapeutics   1.45   
13.0%
0%
IKNAIkena Oncology   2.14   
20.0%
0%
NKTXNkarta   4.26   
40.0%
0%
TPSTTempest Therapeutics   6.90   
65.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in income.
Note that the Molecular Templates information on this page should be used as a complementary analysis to other Molecular Templates' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Consideration for investing in Molecular OTC Stock

If you are still planning to invest in Molecular Templates check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Molecular Templates' history and understand the potential risks before investing.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world